The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi Chrisjse,
I agree that they appear not to be high tech, but I understand that they have an important part to play in regulating the flow through the test strip. So precission presure on the strip is needed.
They have stated in their annual report (extract below) that they are making diagnostic covid related products. So if not LFT then i am not sure what. Maybe in the next update more will be revealed.
As an aside Abbot have recently anounced good profits & growth. One of their products appears to incorporate the Carclo device for diabieties blood collection (high growth area), that Carclo championed as an example of their development expertise on their web site
https://www.globalpointofcare.abbott/en/product-details/afinion2-analyzer.html
From the Chairmans statement.
"As a result of CTP’s reputation for
delivery and quality, the division secured
three new large medical customers.
Two of these customers operate in
the diagnostic field and the other in
pharmaceuticals. Demand for new
COVID products was high and is
expected to remain so for some time,
whilst demand for some non-COVID
medical products reduced as a result
of treatments being delayed.
As a result of these new business wins,
demand for new tooling increased over
the prior year and is an encouraging
leading indicator of future growth.
Investment in new technology moulding
machines also continued at a high level
as the division gears up for increased
demand for medical and diagnostic
products (both COVID and non-COVID
related).
As well as securing new customers, the
division also saw increased demand from
existing customers in the medical sector."
I doubt Carclo are making Lateral flow tests, LFTs are mass market , not high precision and I suspect low margin. If they were making them or kits for PCR I think they would have stated this a long time ago.
encouraging AGM statement looking 4ward results November
Possibly because it finished above the 35p pivot so may have broken the down trend - now need to break and hold above 40/42p
Early action in Carclo this morning, having been smashed over the last month.
Any thoughts?
It also links well with this statement they Made it the trading update 2/9/21
"Alongside the positive trading performance, the division continues to make good commercial progress with order intake in the medical and diagnostic sector remaining strong and showing some good potential.
The new customer programmes announced in December 2020 are moving into production on time and to budget, with these providing significant growth potential from the latter part of FY22."
From various news feeds there seems to be a noticable global swing away from PCR tests towards lateral flow tests, for Covid19 testing.
Would it be too much of an assumption that Carclo's diagnostic 10year contract is for the provision of the multiple high tollerance components needed, for these lateral flow tests (+ the other covid related orders they have confirmed).
The CEO of Avacta (in partnership with GAD Mologic) , mentioned in a recent results presentation that the casing of lateral flows are an intergral part of how the test strip performs, and that they have worked hard with their casing supplier to perfect the product.
This precission manufacturing is right in Carclo's field of expertise and with having factories in the USA, Europe, India, China, & Uk, they are perfectly placed to supply masive domestic & export demand generated in those countries.
Great oppertunity for the Company to make some serious profit, over and above their "day to day" contracts.
24/7 Working at the moment.
Looking forward to the results & trading update in November (not long to wait)
GLA
Is there are risk to Margin in the H1 results from rising energy and logistics costs??…the £2m in gov loans is due to drop in in H1 so should make the accounts look better —- if the rising costs have been offset by increased prices we should be expecting a positive half year result
Any idea when in November we can expect the results?
Last year they gave notice on the 12th Nov 2020 that it would be 27th Nov 2020
So director purchases are not an option at the moment. I don’t mean to wish my life away but the results in November can’t come round quick enough..
30 days interims 60 days finals I believe
Well the 6 months that will be reported in the interims has now finished, Apr to Sept. The trading update told us that the first 4 months were ahead of management expectations. Aviation industry recovering, so expect some more revenue from the Aerospace division. Previous FY results showed underlying earnings per share of 2.9p, so if they can improve on that, the current share price is under a PE of 10. (note I have used the underlying true earnings, not the adjusted earnings which include the pension past service credit).
Checking out some stats on Simply wall street, I saw that they have a 1 year price target of 63p, which sounds reasonable.
I expect the current pricing anomaly will soon be corrected here. I have a modest stake, not betting the house, but hoping for 50% return, which from my buy in of 31.5p is still under 50p. If the interims are good, we should see this before Christmas.
Do any of you guys know if these are now in a ‘closed period’, or are the directors still free to purchase stock?
Hiya Beza,
Friday 30th.
They are hiring for sure.
Hi Frank,
That’s interesting. Thanks for posting. How recent is that job advert?
Join Carclo today and qualify for a $1,000 sign-on bonus!
Job Functions:
Looking for a Hands-on Process Engineer with experience taking molds in and out of presses. Experience developing new processes using material recommended settings. Developing processes using standard development studies. That including cooling, melting, injection velocity and pressure. Must be able to work in a team environment and have ability to take direction from program managers. Candidate will be working on new medical devices, as well as validating equipment relocation presses coming into the ......
There is lots more plus a $100k+salary.
What interested me was "candidate will be working on new medical devices"
I wonder what they are?
Can buy under 30 now.
Took another dose for value (and fact it could reverse anytime) but momentum still seems against this so may get some more even lower.
Didn’t think I would be getting back in this cheaply and kind of makes me question whether something has shifted behind scenes but more likely this is v good value…
Good luck all. Been a good 12 months overall for the SP so hope to see positive sentiment return soon
Bought in today. Lets hope it ends better than last time I bought in 24p to 5p. LOL.
I feel this is over sold now, and I dont read much in to a seller, who as I stated above could have bought at 10p and be realising a healthy profit. 200 SMA @ 37p, so probably just restoring some balance.
There is also defo a buyer scopping up in 50k chunks, been 3-4 today so far, all delyaed by an hour or so, also on the rsp there is way less today on the ask. Think our seller/s offloaded most yesterday.
hopefully down to dreggs now
Of course Warren that is an issue. The company in their last update let us know that they had increased stock levels of raw materials. Let's hope they continue to do so.jmo
Agreed Mesquida. And looking forward to an update (hopefully) early October.
The reason for the drift in share price I feel is the disruption in raw materials that the world is experiencing , unfortunately Carclo will not be immune to these problems .
Results in November will be affected short term but the long term story is still strong, best just to sit tight and ride it out.
Of course you are right, Frank, compliance with the rules is not an option , but i have seen so many "late" holdings RNS's that i do seriously wonder whether the Stock Exchange is policing this with much vigour.
But time will tell, at some point Carclo will have to update the Rule 28 details on its company website, but meanwhile do you agree with me in thinking that these past few days the selling has not been so aggresive/possibly has finished.
Hi Mesquida, happy to be wrong but somehow I doubt the seller was/is Schroders.
As you have said no RNS and for a company this size the rules are the rules & compliance is not an option. And why after all they have been through with this small holding (in the scheme of things) would they sell at this point.
Like you I have been on the lookout for an RNS. There must be a number of holders, even multi funds within one company with just under 3%, my guess is this
is where ethe seller comes from